Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum

Twitter is blocking people from viewing tweets and profiles on its website unless they are signed in to

President Volodymyr Zelenskiy visited troops on Ukraine’s eastern front as the military reported further advances in the south,

By Sinéad Carew Shares of U.S. banks, both major and mid-sized, sharply underperformed the broader market on Wednesday

PALMETTO, Fla.--(BUSINESS WIRE)--Sep 27, 2023--

The surprising resilience of American consumers is about to be tested over the coming months, as rising delinquencies,

Hungarian Prime Minister Viktor Orbán has held talks with Vladimir Putin, becoming the first leader of a European Union nation to meet in person with the Russian president since the beginning of the war in Ukraine

LOS ANGELES (Reuters) -Netflix Inc's recently launched tier that offers lower subscription fees but includes commercials on its programming now

Sweden’s Samhallsbyggnadsbolaget i Norden AB has entered into exclusive discussions with Brookfield Asset Management to sell its remaining

By Jason Xue and Clare Jim SHANGHAI/HONG KONG Faced with a liquidity crisis, Zhongzhi Enterprise Group will conduct

By Jihoon Lee and Cynthia Kim SEOUL (Reuters) -South Korea's exports beat expectations and accelerated in November as overseas sales

A major US opioid settlement is on the verge of unraveling. Mallinckrodt Plc, the drugmaker that first began